Gout News and Research

RSS
Gout is a type of arthritis that causes painful inflammation in the joints. Usually it affects one joint which is most commonly the big toe. However, it can affect any joint in the body such as the ankles, knees, wrists, elbows and any joints in the hands or finger.

Symptoms of gout usually develop rapidly and usually start at night. The joint may then start to feel normal again with any pain or discomfort eventually disappearing . However, most people who get gout will have further attacks in the future.

The symptoms of gout are caused by an above normal level of urate in the bloodstream, which builds up and forms crystals, mainly in and around joints and especially in the finger and toe joints. This can lead to intensely pain and inflammation.

There are several factors that can increase the level of blood urate. These include a diet rich in purines (which form urate when broken down) such as red meat, seafood and some other foods; excess alcohol consumption; the use of certain medicines such as diuretics; a family history of gout; kidney disease; and overweight or obesity.

Gout affects about 1% of the population and is more common in men, particularly those aged 30 to 60, and in women who have already experienced the menopause.
Removing damaged mitochondria may relieve chronic inflammatory conditions

Removing damaged mitochondria may relieve chronic inflammatory conditions

Researchers discover unique approach to treat some chronic inflammatory diseases

Researchers discover unique approach to treat some chronic inflammatory diseases

Gout treatment could potentially reduce complications accompanying metabolic syndrome

Gout treatment could potentially reduce complications accompanying metabolic syndrome

Success for new cholesterol-lowering drug

Success for new cholesterol-lowering drug

Researchers review applications, properties, and pharmacological potentials of rose hip

Researchers review applications, properties, and pharmacological potentials of rose hip

New study solves longstanding mystery in innate immunity

New study solves longstanding mystery in innate immunity

Antidepressant use increased after Brexit vote

Antidepressant use increased after Brexit vote

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

NHS comes up with a list of 20 most painful conditions

NHS comes up with a list of 20 most painful conditions

Study: Nurse-led care can be more successful in managing gout

Study: Nurse-led care can be more successful in managing gout

Genes cause gout not diet

Genes cause gout not diet

OSA patients have higher risk of developing gout, research reveals

OSA patients have higher risk of developing gout, research reveals

Foot specialist explains steps to be taken to mitigate foot-related issues

Foot specialist explains steps to be taken to mitigate foot-related issues

Scientists map regulatory landscape of mouse genome at single-cell resolution

Scientists map regulatory landscape of mouse genome at single-cell resolution

Newly identified target may lead to discovery of treatments for chronic inflammatory diseases

Newly identified target may lead to discovery of treatments for chronic inflammatory diseases

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

A systematic approach towards diagnosis and treatment of rheumatoid arthritis

A systematic approach towards diagnosis and treatment of rheumatoid arthritis

Novel cellular pathway may clarify how arterial inflammation develops into atherosclerosis

Novel cellular pathway may clarify how arterial inflammation develops into atherosclerosis

Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows

Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows

Study shows improvements in adherence, outcomes of gout patients receiving text message reminders

Study shows improvements in adherence, outcomes of gout patients receiving text message reminders